Tag: respiratory medicines
AstraZenca to invest $200m in local manufacturing
AstraZenca has pledged to invest $200m in its manufacturing facility in North Ryde, Sydney as part of its plans to increase exports to $4.4bn...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
